Skip to main content

HPV Vaccine Intent among Adult Women Receiving Care at Community Health Centers

Journal of Cancer Education volume 37, pages 1186–1193 (2022)Cite this article

Abstract

Human papillomavirus (HPV) is a disease that exacts substantial costs in human life and public health expenditures. Fortunately, a vaccine exists that can mitigate these costs. This study reports the development and evaluation of the intervention designed to overcome these barriers by using culturally grounded narratives to promote HPV vaccination. Women’s Stories (WS) targets women over the age of 18 and was originally successfully validated for use among college students resulting in NCI recognition. WS was adapted for touch pad delivery in Planned Parenthood clinics where a randomized clinical trial was conducted in 8 clinics in 3 cities. Two hundred seventeen women were randomly assigned to treatment and control, completing pretest and posttest surveys. This study examined data from the immediate posttest. An intent to treat analysis was conducted using a generalized linear mixed modeling approach using a multinomial link and accounting for repeated measures by site. Results demonstrate significant short-term effects on vaccine intentions and vaccine self-efficacy. When compared to control group participants, women in the treatment condition more likely to intend to get the shot today/the day of interview (p < 0.01), as well as in 1 (p < 0.01) and 6 (p < 0.01) months and had greater self-efficacy to receive the HPV vaccination (B = 0.54; p = 0.0002). These results are promising for the potential impact of the intervention in clinical settings as well as providing a model for overcoming lack of awareness and vaccine resistance in other segments of the population.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

39,95 €

Price includes VAT (Finland)

Data Availability

Data is available by request.

References

  1. Boersma P, Black LI (2020) Human papillomavirus vaccination among adults aged 18–26, 2013–2018. National Center for Health Statistics, Atlanta

    Google Scholar 

  2. Dunne EF, Unger ER, Sternberg M, McQuillan G, Swan DC, Patel SS, Markowitz LE (2007) Prevalence of HPV infection among females in the United States. J Am Med Assoc 297:813–819

    Article  CAS  Google Scholar 

  3. Munoz N, Castellsague X (2006) Berrington de Gonzalez a, Gissmann L. chapter 1: HPV in the etiology of human cancer. Vaccine. 24(S3):S3/1–S3/10

    CAS  Google Scholar 

  4. Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Altekruse SF, Kosary CL, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Chen HS, Feuer EJ, Cronin KA (2012) SEER Cancer Statistics Review (CSR) 1975–2009. Available from: http://seer.cancer.gov/csr/1975_2009_pops09/

  5. Human papillomavirus (2007) IARC monographs on the evaluation of carcinogenic risks to humans. 90:16–36

  6. Centers for Disease Control and Prevention (2019). Human papillomavirus vaccine information statements. Retrieved from https://www.cdc.gov/vaccines/hcp/vis/vis-statements/hpv.html

  7. Centers for Disease Control and Prevention. (2019). Human papillomavirus. Retrieved from https://www.cdc.gov/hpv/parents/vaccine.html

  8. Musselwhite LW, Oliveira CM, Kwaramba T et al (2016) Racial/ethnic disparities in cervical cancer screening and outcomes. Acta Cytol 60(6):518–526. https://doi.org/10.1159/000452240

    Article  PubMed  Google Scholar 

  9. Lukács A, Máté Z, Farkas N et al (2020) The quadrivalent HPV vaccine is protective against genital warts: a meta-analysis. BMC Public Health 20(1):691. Published 2020 May 28. https://doi.org/10.1186/s12889-020-08753-y

    Article  PubMed  PubMed Central  Google Scholar 

  10. Boersma P, Black LI (2020) Human papillomavirus vaccination among adults aged 18–26, 2013–2018. NCHS Data Brief, no 354. Hyattsville, MD: National Center for Health Statistics

  11. Hopfer S, Wright ME, Pellman H, Wasserman R, Fiks AG (2019) HPV vaccine recommendation profiles among a national network of pediatric practitioners: understanding contributors to parental vaccine hesitancy and acceptance. Human Vaccine & Immunotherapeutics. https://doi.org/10.1080/21645515.2018.1560771

  12. Dempsey A, Cohn L, Vanessa D, Mack R (2011) Worsening disparities in HPV vaccine utilization among 19–26 year old women. Vaccine. 29(3):528–534

    Article  Google Scholar 

  13. Brown M (2013) Overall HPV vaccination rates stagnant: series completion dipping. American Academy of Family Practitioners (AAFP); [updated 2013; cited 2013 November 8]; Available from: http://www.aafp.org/news-now/health-of-the-public/20130802hpv-vaccine-rates.html

  14. Dorell CG, Yankey D, Santibanez TA, Markowitz L (2011) Human papillomavirus vaccination series initiation and completion, 2008-2009. Pediatrics. 128:830–839

    Article  Google Scholar 

  15. Neubrand TPL, Breitkopf CR, Rupp R, Breitkopf D, Rosenthal SL (2009) Factors associated with completion of the human papillomavirus vaccine series. Clin Pediatr 48:966–969

    Article  Google Scholar 

  16. Hopfer, S., Ray, A. E., Hecht, M. L., Miller-Day, M., Belue, R., Zimet, G., Evans, W. D., McKee, F. X. (2018) Taking an HPV vaccine research tested intervention to scale in a clinical setting, translational behavioral medicine, 8:5, 745–752. https://doi.org/10.1093/tbm/ibx066

  17. Hopfer S (2012) Effects of a narrative HPV vaccine intervention aimed at reaching college women: a randomized controlled trial. Prev Sci 13:173–182. https://doi.org/10.1007/s11121-011-0254-1

    Article  PubMed  Google Scholar 

  18. Miller-Day M, Hecht ML, Krieger JL, Pettigrew J, Shin Y, Graham J (2015) Teacher narratives and student engagement: testing narrative engagement theory in drug prevention education. J Lang Soc Psychol 34(6):604–620. https://doi.org/10.1177/0261927X15586429

    Article  PubMed  PubMed Central  Google Scholar 

  19. Krieger JL, Coveleski S, Hecht ML et al (2013) From kids, through kids, to kids: examining the social influence strategies used by adolescents to promote prevention among peers. Health Commun 28(7):683–695. https://doi.org/10.1080/10410236.2012.762827

    Article  PubMed  PubMed Central  Google Scholar 

  20. Gerend MA, Shepherd JE (2012) Predicting human papillomavirus vaccine uptake in young adult women: comparing the health belief

  21. de Oliveira CM, Fregnani JHTG, Villa LL (2019) HPV vaccine: updates and highlights. Acta Cytol 63(2):159–168. https://doi.org/10.1159/000497617

    Article  CAS  PubMed  Google Scholar 

  22. Stanley M (2014) HPV vaccination in boys and men. Hum Vaccin Immunother 10(7):2109–2111. https://doi.org/10.4161/hv.2913739

    Article  PubMed  PubMed Central  Google Scholar 

  23. Brotherton JM, Budd A, Rompotis C et al (2019) Is one dose of human papillomavirus vaccine as effective as three?: a national cohort analysis. Papillomavirus Res 8:100177. https://doi.org/10.1016/j.pvr.2019.100177

    Article  PubMed  PubMed Central  Google Scholar 

  24. Squire C (2009) Experience-centered and culturally-oriented approaches to narrative. In: Andrews M, Squire C, Tamboukou M (eds) Doing narrative research. Sage, London, UK

    Google Scholar 

  25. Strauss A, Corbin J (1998) Basics of qualitative research. Sage, Thousand Oaks

    Google Scholar 

  26. Hecht ML, Miller-Day M (2009) Drug resistance strategies project: using narrative theory to enhance adolescents’ communication competence. In: Cissna K, Frey L (eds) Handbook of applied communication: exemplary programs. Routledge, New York

    Google Scholar 

  27. Hopfer S, Clippard JR (2010) College women’s HPV vaccine decision narratives. Qual Health Res 21:262–277

    Article  Google Scholar 

  28. Miller-Day M (2008) Translational performances: toward relevant, engaging, and empowering social science. Forum: qualitative social research. 9(2):Art. 54

  29. Garganto LM, Herbert NL, Sales JM, Morfaw C, Rask K (2013) Impact of a physician recommendation and parental immunization attitudes on receipt or intention to receive adolescent vaccines. Human Vaccine Immunotherapeutics 9:2627–2633

    Article  Google Scholar 

  30. Cole-Lewis H, Kershaw T (2010) Text messaging as a tool for behavior change in disease prevention and management. Epidemiol Rev 32:56–69

    Article  Google Scholar 

  31. Krishna S, Boren SA, Balas EA (2009) Healthcare via cell phones: a systematic review. Telemedicine and e-Health 15:231–240

    Article  Google Scholar 

  32. Jordan ET, Ray E, Johnson P, Evans WD (2011) Using text messaging to improve maternal and newborn health. Nursing for women’s health 15:206–212

    Article  Google Scholar 

  33. Fishbach S (2012) New study shows how mobile reminders can help HIV+patients. Mobile Commons. Brooklyn, NY

  34. Kharbanda EO, Stockwell MS, Fox HW, Rickert VI (2009) Text4Health: a qualitative evaluation of parental readiness for text message immunization reminders. Am J Public Health 99:2176–2178

    Article  Google Scholar 

  35. McAfee (http://standrew.com/AHRQ/AHRQ_Innovation_Profile_Kiosk.pdf)

  36. Wegwarth O, Kurzenhäuser-Carstens S, Gigerenzer G (2014) Overcoming the knowledge–behavior gap: the effect of evidence-based HPV vaccination leaflets on understanding, intention, and actual vaccination decision. Vaccine 32(12):1388–1393

    Article  CAS  Google Scholar 

  37. Kahn JA, Rosenthal SL, Jin Y, Huang B, Namakydoust A, Zimet GD (2008) Rates of human papillomavirus vaccination, attitudes about vaccination, and human papillomavirus prevalence in young women. Obstet Gynecol 111(5):1103–1110. https://doi.org/10.1097/AOG.0b013e31817051fa

    Article  PubMed  Google Scholar 

  38. Larson HJ, Jarrett C, Schulz WS et al (2015) Measuring vaccine hesitancy: the development of a survey tool. Vaccine 33(34):4165–4175. https://doi.org/10.1016/j.vaccine.2015.04.037

    Article  PubMed  Google Scholar 

  39. Corace KM, Srigley JA, Hargadon DP, Yu D, MacDonal TK, Fabrigar LR, Garber GE (2016) Using behavior change frameworks to improve healthcare worker influenza vaccination rates: a systematic review. Vaccine 34(28):3235–3242. https://doi.org/10.1016/j.vaccine.2016.04.071

    Article  PubMed  Google Scholar 

  40. Gilca V, Sauvageau C, Panicker G, De Serres G, Ouakki M, Unger ER (2018) Immunogenicity and safety of a mixed vaccination schedule with one dose of nonavalent and one dose of bivalent HPV vaccine versus two doses of nonavalent vaccine - a randomized clinical trial. Vaccine 36(46):7017–7024. https://doi.org/10.1016/j.vaccine.2018.09.05

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Funding

This journal article was supported by the Grant or Cooperative Agreement Number, 5 R44DP006291–03, funded by the Centers for Disease Control and Prevention. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Centers for Disease Control and Prevention or the Department of Health and Human Services.

Author information

Authors and Affiliations

  1. REAL Prevention LLC, Clifton, NJ, USA

    M. L. Hecht

  2. Health Management and Policy, Saint Louis University, St Louis, MO, USA

    R. BeLue

  3. Public Health, University of Kentucky, Lexington, KY, USA

    A. Ray

  4. Public Health, UC Irvine, Irvine, CA, USA

    S. Hopfer

  5. Communication Studies, Chapman University, Orange, CA, USA

    M. Miller-Day

  6. St. Andrew Development, Inc., Philadelphia, PA, USA

    F. Mckee

Authors
  1. M. L. Hecht
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. BeLue
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Ray
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S. Hopfer
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M. Miller-Day
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. F. Mckee
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Design of the work: Hecht, Wray, Hopfer, and Miller-Day.

Data collection: McKee and Ray.

Data analysis and interpretation: BeLue.

Drafting the article: BeLue and Hecht.

Corresponding author

Correspondence to R. BeLue.

Ethics declarations

Competing Interests

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this article.

Ethics Approval

The study was approved by the IRB of the lead author and second authors’ institutions.

Consent to Participate

Informed consent was obtained from all individual participants included in the study.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hecht, M.L., BeLue, R., Ray, A. et al. HPV Vaccine Intent among Adult Women Receiving Care at Community Health Centers. J Canc Educ 37, 1186–1193 (2022). https://doi.org/10.1007/s13187-020-01937-5

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13187-020-01937-5

Keywords

  • Human papillomavirus (HPV) vaccine
  • Narrative intervention
  • Women’s stories